$72.50
$66.10
$176.19
$66.21
$2.3B
-6.35%
This is a preview of the full version of Prosperse
OrthoPediatrics Corp. (KIDS) has launched its Enabling Technologies division, which will leverage the company's core mission of addressing unmet pediatric needs in orthopedics. The new division is expected to differentiate KIDS' core business, generate sustainable revenue growth, and gain access to ...
Zacks
Sep 16, 2024
Paragon 28 has launched a new Right-Angle Drill for its APEX 3D Total Ankle Replacement System, which is expected to improve the long-term success of ankle replacements. The company's stock gained 3.1% following the launch.
Zacks
Sep 11, 2024
TransMedics, a leader in organ transplant technologies, has seen its stock price experience wild volatility due to its revolutionary Organ Care System, high sales growth, and newfound profitability. Despite the company's first-mover advantage, its valuation remains high, requiring a long-term invest...
Josh Kohn-Lindquist
Sep 5, 2024
TransMedics (TMDX) has seen a significant improvement in its earnings outlook, with analysts raising their estimates for the company. This positive trend in earnings estimate revisions is driving the stock's performance and could continue to push it higher.
Zacks Investment Research
Aug 7, 2024
TransMedics reported strong Q2 2024 earnings, with revenue up 117.9% year-over-year and EPS of $0.35 compared to -$0.03 in the prior year. The company's performance exceeded analyst estimates across key metrics like geographic revenues and net revenue by product line.
Zacks.Com
Aug 2, 2024
TransMedics Group (TMDX) reported strong Q2 results, with revenue up 118% year-over-year and net income of $12.2 million. The company also raised its full-year revenue guidance. The stock gained 11.1% on the news.
Keith Speights
Aug 1, 2024
Date: Nov 19, 2024
Date: Nov 19, 2024
Date: Nov 14, 2024
Date: Nov 14, 2024
Date: Nov 14, 2024